Home › NDC Lookup › RxCUI directory › RxCUI 284245

Famotidine 40 MG Oral Tablet — RxCUI 284245

RxNorm drug concept · Semantic clinical drug
RxCUI 284245 Semantic clinical drug · SCD ● Current RxNorm concept 91 FDA products 301 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI284245
Official nameFamotidine 40 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped91
Package NDCs mapped301
Reported Medicaid activity (SDUD)5,270,237 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Famotidine Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It lowers stomach acid. It's used in the hospital for ulcers, GERD, or excess-acid conditions, especially when you can't take pills. It's typically used until you can switch to ora...
  • Why am I getting famotidine through an IV?
  • For adults it is generally given about every 12 hours through a vein. Your care team will set the exact dose and timing, which may be adjusted if your kidneys aren't working well.
  • The common ones are headache, dizziness, constipation, and diarrhea. You may also notice brief irritation where the IV goes in. Tell your nurse about any of these.
📖 Read our full Famotidine Injection guide →

🕸️ Concept Web — How Famotidine 40 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Famotidine 40 MG Oral Tablet RxCUI 284245

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Famotidine 4278
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Pepcid 196458
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Famotidine Oral Tablet 372140
    • Famotidine Oral Product 1159021
    • Famotidine Pill 1159022
    • Famotidine Oral Tablet [Pepcid] 93732
    • Pepcid Oral Product 1185206
    • Pepcid Pill 1185207
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Famotidine 40 MG SCDC · 317369
  • Famotidine Oral Tablet SCDF · 372140
  • Famotidine Oral Product SCDG · 1159021
  • Famotidine Pill SCDG · 1159022

Brand-Name Concepts

  • Famotidine 40 MG Oral Tablet [Pepcid] SBD · 104095
  • Famotidine 40 MG [Pepcid] SBDC · 491221
  • Famotidine Oral Tablet [Pepcid] SBDF · 93732
  • Pepcid Oral Product SBDG · 1185206
  • Pepcid Pill SBDG · 1185207
  • Pepcid BN · 196458

📦 FDA Products & Package NDCs

91 products · 301 package NDCs
301 package NDCs map to RxCUI 284245 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00172-5728-60 100 TABLET, FILM COATED in 1 BOTTLE (0172-5728-60) Famotidine Teva Pharmaceuticals USA, Inc. 2001-04-16
00172-5728-70 500 TABLET, FILM COATED in 1 BOTTLE (0172-5728-70) Famotidine Teva Pharmaceuticals USA, Inc. 2001-04-16
00172-5728-80 1000 TABLET, FILM COATED in 1 BOTTLE (0172-5728-80) Famotidine Teva Pharmaceuticals USA, Inc. 2001-04-16
00172-5729-60 100 TABLET, FILM COATED in 1 BOTTLE (0172-5729-60) Famotidine Teva Pharmaceuticals USA, Inc. 2001-04-16
00172-5729-70 500 TABLET, FILM COATED in 1 BOTTLE (0172-5729-70) Famotidine Teva Pharmaceuticals USA, Inc. 2001-04-16
00187-4420-10 100 TABLET, FILM COATED in 1 BOTTLE (0187-4420-10) Pepcid Bausch Health US LLC 2001-04-16
00187-4420-30 30 TABLET, FILM COATED in 1 BOTTLE (0187-4420-30) Pepcid Bausch Health US LLC 2001-04-16
00187-4440-10 100 TABLET, FILM COATED in 1 BOTTLE (0187-4440-10) Pepcid Bausch Health US LLC 2001-04-16
00187-4440-30 30 TABLET, FILM COATED in 1 BOTTLE (0187-4440-30) Pepcid Bausch Health US LLC 2001-04-16
00615-8558-05 15 TABLET in 1 BLISTER PACK (0615-8558-05) Famotidine NCS HealthCare of KY, LLC dba Vangard Labs 2025-01-16
00615-8558-28 28 TABLET in 1 BLISTER PACK (0615-8558-28) Famotidine NCS HealthCare of KY, LLC dba Vangard Labs 2025-01-16
00615-8558-39 30 TABLET in 1 BLISTER PACK (0615-8558-39) Famotidine NCS HealthCare of KY, LLC dba Vangard Labs 2025-01-16
00615-8559-05 15 TABLET in 1 BLISTER PACK (0615-8559-05) Famotidine NCS HealthCare of KY, LLC dba Vangard Labs 2025-01-14
00615-8559-39 30 TABLET in 1 BLISTER PACK (0615-8559-39) Famotidine NCS HealthCare of KY, LLC dba Vangard Labs 2025-01-14
10267-5689-01 100 TABLET, COATED in 1 BOTTLE (10267-5689-1) Famotidine Contract Pharmacal Corp. 2024-08-31
10267-5689-04 1000 TABLET, COATED in 1 BOTTLE (10267-5689-4) Famotidine Contract Pharmacal Corp. 2024-08-31
10267-5689-05 500 TABLET, COATED in 1 BOTTLE (10267-5689-5) Famotidine Contract Pharmacal Corp. 2024-08-31
10267-5690-01 100 TABLET, COATED in 1 BOTTLE (10267-5690-1) Famotidine Contract Pharmacal Corp. 2024-08-31
10267-5690-04 1000 TABLET, COATED in 1 BOTTLE (10267-5690-4) Famotidine Contract Pharmacal Corp. 2024-08-31
10267-5690-05 500 TABLET, COATED in 1 BOTTLE (10267-5690-5) Famotidine Contract Pharmacal Corp. 2024-08-31
31722-0017-01 100 TABLET, FILM COATED in 1 BOTTLE (31722-017-01) Famotidine Camber Pharmaceuticals, Inc. 2021-11-04
31722-0017-10 1000 TABLET, FILM COATED in 1 BOTTLE (31722-017-10) Famotidine Camber Pharmaceuticals, Inc. 2021-11-04
31722-0018-01 100 TABLET, FILM COATED in 1 BOTTLE (31722-018-01) Famotidine Camber Pharmaceuticals, Inc. 2021-11-04
31722-0018-05 500 TABLET, FILM COATED in 1 BOTTLE (31722-018-05) Famotidine Camber Pharmaceuticals, Inc. 2021-11-04
31722-0018-10 1000 TABLET, FILM COATED in 1 BOTTLE (31722-018-10) Famotidine Camber Pharmaceuticals, Inc. 2021-11-04
43063-0533-30 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-533-30) Famotidine PD-Rx Pharmaceuticals, Inc. 2014-04-14
43063-0696-30 30 TABLET in 1 BOTTLE, PLASTIC (43063-696-30) Famotidine PD-Rx Pharmaceuticals, Inc. 2016-07-26
43063-0696-90 90 TABLET in 1 BOTTLE, PLASTIC (43063-696-90) Famotidine PD-Rx Pharmaceuticals, Inc. 2016-07-26
43063-0696-93 180 TABLET in 1 BOTTLE, PLASTIC (43063-696-93) Famotidine PD-Rx Pharmaceuticals, Inc. 2016-07-26
43063-0696-95 1000 TABLET in 1 BOTTLE, PLASTIC (43063-696-95) Famotidine PD-Rx Pharmaceuticals, Inc. 2021-05-11
46708-0293-10 100 TABLET in 1 CARTON (46708-293-10) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0293-30 30 TABLET in 1 BOTTLE (46708-293-30) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0293-31 100 TABLET in 1 BOTTLE (46708-293-31) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0293-71 500 TABLET in 1 BOTTLE (46708-293-71) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0293-91 1000 TABLET in 1 BOTTLE (46708-293-91) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0294-10 100 TABLET in 1 CARTON (46708-294-10) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0294-30 30 TABLET in 1 BOTTLE (46708-294-30) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0294-31 100 TABLET in 1 BOTTLE (46708-294-31) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0294-71 500 TABLET in 1 BOTTLE (46708-294-71) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
46708-0294-91 1000 TABLET in 1 BOTTLE (46708-294-91) Famotidine Alembic Pharmaceuticals Limited 2016-01-29
50090-1045-00 30 TABLET in 1 BOTTLE (50090-1045-0) Famotidine A-S Medication Solutions 2014-11-28
50090-1045-01 20 TABLET in 1 BOTTLE (50090-1045-1) Famotidine A-S Medication Solutions 2014-11-28
50090-1045-02 60 TABLET in 1 BOTTLE (50090-1045-2) Famotidine A-S Medication Solutions 2014-11-28
50090-1045-03 90 TABLET in 1 BOTTLE (50090-1045-3) Famotidine A-S Medication Solutions 2018-03-12
50090-1432-00 30 TABLET in 1 BOTTLE (50090-1432-0) Famotidine A-S Medication Solutions 2014-11-28
50090-1432-01 90 TABLET in 1 BOTTLE (50090-1432-1) Famotidine A-S Medication Solutions 2020-12-03
50090-6790-00 30 TABLET, FILM COATED in 1 BOTTLE (50090-6790-0) Famotidine A-S Medication Solutions 2023-10-31
50090-6790-01 90 TABLET, FILM COATED in 1 BOTTLE (50090-6790-1) Famotidine A-S Medication Solutions 2023-10-31
50090-6916-00 90 TABLET, FILM COATED in 1 BOTTLE (50090-6916-0) Famotidine A-S Medication Solutions 2023-12-13
50090-7196-00 90 TABLET, FILM COATED in 1 BOTTLE (50090-7196-0) Famotidine A-S Medication Solutions 2024-07-24
Observed labelers: Bryant Ranch Prepack (54) · Proficient Rx LP (31) · Sportpharm LLC (18) · A-S Medication Solutions (14) · Alembic Pharmaceuticals Inc. (10) · Alembic Pharmaceuticals Limited (10) · +30 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.